Diphtheria, Tetanus, and Pertussis Vaccine Resources

DT Vaccine Discontinuation

In 2023, Sanofi Pasteur, Inc. will stop manufacturing the diphtheria and tetanus toxoids absorbed vaccine, commonly known as DT.

CDC currently recommends DT for infants and children who should not receive acellular pertussis-containing vaccines. Discussions are underway regarding updated vaccine recommendations for these children.

Below are a number of resources designed to help healthcare personnel recommend and administer diphtheria, tetanus, and pertussis vaccines, as well as answer patient questions.

Vaccine Safety

Provider Education

Materials for Patients

Clinical Information

References and Resources